| Race, risk, and willingness of end-stage renal disease patients without hepatitis C virus to accept an HCV-infected kidney transplant M McCauley, A Mussell, D Goldberg, D Sawinski, RN Molina, R Tomlin, ... Transplantation 102 (4), e163-e170, 2018 | 36 | 2018 |
| Homologous recombination repair deficiency as a therapeutic target in sarcoma J Oza, SD Doshi, L Hao, E Musi, GK Schwartz, M Ingham Seminars in oncology 47 (6), 380-389, 2020 | 28 | 2020 |
| Waitlisted candidates with polycystic liver disease are more likely to be transplanted than those with chronic liver failure SD Doshi, T Bittermann, TD Schiano, DS Goldberg Transplantation 101 (8), 1838-1844, 2017 | 22 | 2017 |
| An automated text message navigation program improves the show rate for outpatient colonoscopy N Mahmud, SD Doshi, MS Coniglio, M Clermont, D Bernard, C Reitz, ... Health Education & Behavior 46 (6), 942-946, 2019 | 19 | 2019 |
| The changing burden of alcoholic hepatitis: rising incidence and associations with age, gender, race, and geography SD Doshi, MJ Stotts, RA Hubbard, DS Goldberg Digestive diseases and sciences 66, 1707-1714, 2021 | 14 | 2021 |
| Transient elastography reliably estimates liver fibrosis in autoimmune hepatitis N Mahmud, S Doshi, K Forde, V Khungar Clinical and Experimental Hepatology 5 (3), 244-249, 2019 | 11 | 2019 |
| Outcomes of living-donor liver transplantation using grafts heterozygous for α-1 antitrypsin gene mutations SD Doshi, L Wood, PL Abt, KM Olthoff, A Shaked, DS Goldberg, ... Transplantation 103 (6), 1175-1180, 2019 | 10 | 2019 |
| Clinical benefit from immune checkpoint blockade in sclerosing epithelioid fibrosarcoma: a translocation-associated sarcoma SD Doshi, J Oza, H Remotti, F Remotti, MP Moy, GK Schwartz, M Ingham JCO Precision Oncology 5, 1-5, 2021 | 6 | 2021 |
| Factors associated with patients not receiving oral anticancer drugs SD Doshi, MRL Lichtenstein, MP Beauchemin, R Raghunathan, S Lee, ... JAMA Network Open 5 (10), e2236380-e2236380, 2022 | 4 | 2022 |
| Association between insurance plan, prior authorization, and time to receipt of oral anticancer drugs. MRL Lichtenstein, MP Beauchemin, RR Raghunathan, SD Doshi, C Law, ... Journal of Clinical Oncology 39 (28_suppl), 6-6, 2021 | 4 | 2021 |
| Impact of a hospital-based specialty pharmacy in partnership with a care coordination organization on time to delivery and receipt of oral anticancer drugs MP Beauchemin, MRL Lichtenstein, R Raghunathan, SD Doshi, S Lee, ... JCO Oncology Practice 19 (3), e326-e335, 2023 | 3 | 2023 |
| A phase II trial of sitravatinib, a multireceptor tyrosine kinase inhibitor, in patients with advanced well-differentiated/dedifferentiated liposarcoma. J Oza, S Doshi, SM Lee, BA Van Tine, E Choy, PJ Oppelt, ... Journal of Clinical Oncology 39 (15_suppl), 11513-11513, 2021 | 3 | 2021 |
| A Single-Arm Phase II Trial of Sitravatinib in Advanced Well-Differentiated/Dedifferentiated Liposarcoma M Ingham, S Lee, BA Van Tine, E Choy, J Oza, S Doshi, L Ge, P Oppelt, ... Clinical Cancer Research 29 (6), 1031-1039, 2023 | 2 | 2023 |
| Impact of a hospital specialty pharmacy in partnership with a free-standing care coordination organization on time to delivery and receipt of oral anticancer drugs. MP Beauchemin, MRL Lichtenstein, RR Raghunathan, SD Doshi, C Law, ... Journal of Clinical Oncology 39 (28_suppl), 43-43, 2021 | 2 | 2021 |
| A phase II trial with safety lead-in to evaluate the addition of APX005M, a CD40 agonistic monoclonal antibody, to standard-of-care doxorubicin chemotherapy for the treatment … M Ingham, SM Lee, S Doshi, S Hernandez, SV Singh-Kandah, Z Singer, ... Journal of Clinical Oncology 38 (5_suppl), TPS85-TPS85, 2020 | 2 | 2020 |
| Automated Text Message Navigation to Improve Preparation Quality and Show Rate for Colonoscopy: 121 N Mahmud, S Doshi, M Coniglio, M Clermont, D Bernard, C Reitz, ... Official journal of the American College of Gastroenterology| ACG 113, S64, 2018 | 2 | 2018 |
| Telemedicine and Cancer Care: Barriers and Strategies to Optimize Delivery SD Doshi, EM Bange, B Daly, G Kuperman, KS Panageas, MJ Morris The Cancer Journal 30 (1), 8-15, 2024 | 1 | 2024 |
| Association Between Copayment Assistance, Insurance Type, Prior Authorization, and Time to Receipt of Oral Anticancer Drugs MRL Lichtenstein, MP Beauchemin, R Raghunathan, S Lee, SD Doshi, ... JCO Oncology Practice 20 (1), 85-92, 2024 | 1 | 2024 |
| Hypoxia-inducible factor-2 alpha (HIF-2α) target activation and clinical outcomes in 942 patients with clear cell renal cell carcinoma. SD Doshi, F Kuo, A Knezevic, RR Kotecha, RJ Motzer, AA Hakimi, ... Journal of Clinical Oncology 42 (4_suppl), 445-445, 2024 | | 2024 |
| Disparities with influenza vaccine use in long-term survivors of metastatic breast cancer SD Doshi, D DeStephano, MK Accordino, E Elkin, RR Raghunathan, ... Breast Cancer Research and Treatment 203 (1), 111-119, 2024 | | 2024 |
